Safety Alerts & Recalls
What does this mean?
This recall for Glipizide and Metformin 2.5 mg /250 mg, 2.5 mg/250 mg and 5 mg/500 mg tablets from CorePharma, LLC was issued at a warehouse/pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. However, if you take Glipizide and Metformin tablets, you may wish to check your medicine - if you see any metal particles in your tablets, take your prescription to your pharmacist to examine.
If you take Glipizide and Metformin tablets and have any other concerns or questions, you should follow up with your doctor.
CorePharma, LLC Recalls Select Lots of Glipizide and Metformin Tablets
CorePharma, LLC is recalling several lots of Glipizide and Metformin 2.5 mg /250 mg, 2.5 mg/500 mg and 5 mg/500 mg tablets because it is possible that the tablets contain tiny pieces of metal.
The following lot numbers have been recalled: 1) Glipizide and Metformin Tablets 2.5 mg/250 mg - Lot numbers 100606 and 102466
2) Glipizide and Metformin Tablets 2.5 mg/500 mg - Lot numbers CPI870, CPB931, 100387, 100824, 101101, 101651, 102482, and 102483
3) Glipizde and Metformin Tablets 5 mg/500 mg - Lot numbers CPK825, CPB914, CPB915, 100353, 100354, 100573, 100602, 100939, 101096, 101097, 101652, 101653, 102484, 102486, and 102485
Glipizide and Metformin tablets are used in the treatment of diabetes. The combination of Glipizide and Metformin is also sold under the brand name Metaglip. This recall alert only applies to the select lots of the generic Glipizide and Metformin tablets made by CorePharma, LLC. No other lots, strengths, or brands were involved in this recall.
To view the FDA notice about this recall, please visit: more information here